Iryna Lobanova
Overview
Explore the profile of Iryna Lobanova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
409
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishfaq M, Gulraiz S, Huang W, Lobanova I, Martin R, French B, et al.
Interv Neuroradiol
. 2022 Apr;
29(2):157-164.
PMID: 35450475
Background: We performed this meta-analysis of randomized clinical trials to compare the outcomes in patients treated with endovascular thrombectomy who receive prior intravenous thrombolysis with those who do not receive...
2.
Qureshi A, Huang W, Lobanova I, Ishfaq M, French B, Siddiq F, et al.
Neurosurgery
. 2022 Mar;
90(6):717-724.
PMID: 35271515
Background: Clopidogrel bolus is an option used before carotid artery stent (CAS) placement when sustained clopidogrel pretreatment is not used. Objective: To compare the effect of clopidogrel bolus (450 mg...
3.
Qureshi A, Lobanova I, Huang W, Ishfaq M, Broderick J, Cassarly C, et al.
Neurocrit Care
. 2021 Dec;
36(2):662-681.
PMID: 34940927
One of the challenges in bringing new therapeutic agents (since nimodipine) in for the treatment of cerebral ischemia associated with aneurysmal subarachnoid hemorrhage (aSAH) is the incongruence in therapeutic benefit...
4.
Qureshi A, Huang W, Lobanova I, Chandrasekaran P, Hanley D, Hsu C, et al.
Stroke
. 2021 Nov;
53(4):1226-1234.
PMID: 34844422
Background: We evaluated the effect of persistent hyperglycemia on outcomes in 1000 patients with intracerebral hemorrhage enrolled within 4.5 hours of symptom onset. Methods: We defined moderate and severe hyperglycemia...
5.
Qureshi A, Rheaume C, Huang W, Lobanova I, Govindarajan R, French B, et al.
Neurologist
. 2021 Nov;
26(6):225-230.
PMID: 34734898
Background: To determine the exposure risk for coronavirus 2019 (COVID-19) during neurology practice. Neurological manifestations of COVID-19 are increasingly being recognized mandating high level of participation by neurologists. Methods: An...
6.
Qureshi A, Pfeiffer K, Babar S, Huang W, Lobanova I, Ishfaq M, et al.
J Neuroimaging
. 2021 Aug;
31(6):1126-1134.
PMID: 34388298
Background And Purpose: We report the results of intra-arterial injection of lidocaine in the middle meningeal artery in patients with intractable headache or status migrainosus. Methods: We treated four patients...
7.
Qureshi A, Huang W, Lobanova I, Ishfaq M, French B, Siddiq F, et al.
World Neurosurg
. 2021 Aug;
154:e671-e676.
PMID: 34352429
Objective: To identify rates of and factors associated with repeat revascularization in a large cohort of patients prospectively followed over 10 years in Carotid Revascularization Endarterectomy versus Stenting Trial. Methods:...
8.
Qureshi A, Baskett W, Huang W, Shyu D, Myers D, Lobanova I, et al.
Ethn Dis
. 2021 Jul;
31(3):389-398.
PMID: 34295125
Objective: To identify differences in short-term outcomes of patients with coronavirus disease 2019 (COVID-19) according to various racial/ethnic groups. Design: Analysis of Cerner de-identified COVID-19 dataset. Setting: A total of...
9.
Qureshi A, Baskett W, Huang W, Myers D, Lobanova I, Ishfaq M, et al.
Neurocrit Care
. 2021 Jul;
36(1):259-265.
PMID: 34231186
Background: To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage...
10.
Qureshi A, Baskett W, Huang W, Shyu D, Myers D, Lobanova I, et al.
World Neurosurg
. 2021 May;
151:e615-e620.
PMID: 33940263
Background: Intracranial hemorrhage (including subarachnoid hemorrhage [SAH]) has been reported in 0.3%-1.2% of patients with coronavirus disease 2019 (COVID-19). However, no study has evaluated the risk of SAH in patients...